MKL1 regulates hepatocellular carcinoma cell proliferation, migration and apoptosis via the COMPASS complex and NF-κB signaling

[1]  Baoyu Chen,et al.  MKL1 promotes endothelial-to-mesenchymal transition and liver fibrosis by activating TWIST1 transcription , 2019, Cell Death & Disease.

[2]  M. Yuen,et al.  Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma , 2019, BMC Cancer.

[3]  P. ten Dijke,et al.  Epigenetic Reprogramming of TGF-β Signaling in Breast Cancer , 2019, Cancers.

[4]  Robert E. Lewis,et al.  WDR5 supports colon cancer cells by promoting methylation of H3K4 and suppressing DNA damage , 2018, BMC Cancer.

[5]  M. Tanabe,et al.  Current topics in the surgical treatments for hepatocellular carcinoma , 2018, Annals of gastroenterological surgery.

[6]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[7]  H. Sakagami,et al.  Synaptic localisation of SRF coactivators, MKL1 and MKL2, and their role in dendritic spine morphology , 2018, Scientific Reports.

[8]  Caroline L. Wilson,et al.  Epigenetic reprogramming in liver fibrosis and cancer☆ , 2017, Advanced drug delivery reviews.

[9]  Xiaohong Yan,et al.  Molecular mechanisms of pathogenesis in hepatocellular carcinoma revealed by RNA-sequencing , 2017, Molecular medicine reports.

[10]  S. Shroff,et al.  Pharmacological intervention of MKL/SRF signaling by CCG-1423 impedes endothelial cell migration and angiogenesis , 2017, Angiogenesis.

[11]  M. Fang,et al.  MKL1 links epigenetic activation of MMP2 to ovarian cancer cell migration and invasion. , 2017, Biochemical and biophysical research communications.

[12]  J. Rowe,et al.  Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis , 2017, Journal of carcinogenesis.

[13]  M. Jayachandran.  An Updated Portrait of Pathogenesis, Molecular Markers and Signaling Pathways of Hepatocellular Carcinoma. , 2017, Current pharmaceutical design.

[14]  J. Issa,et al.  The promise of epigenetic therapy: reprogramming the cancer epigenome. , 2017, Current opinion in genetics & development.

[15]  T. Gudermann,et al.  The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma , 2017, Oncogene.

[16]  A. Sharif,et al.  Diverse Signaling Pathways and Current Status of Molecular Targeted Treatments for Hepatocellular Carcinoma. , 2017, Critical reviews in eukaryotic gene expression.

[17]  I. Ng,et al.  Molecular Pathogenesis of Hepatocellular Carcinoma. , 2016, Liver cancer.

[18]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[19]  Liping Zhang,et al.  Myocardin-related transcription factor A (MRTF-A) plays an essential role in hepatic stellate cell activation by epigenetically modulating TGF-β signaling. , 2016, The international journal of biochemistry & cell biology.

[20]  T. Gudermann,et al.  Filamin A interacts with the coactivator MKL1 to promote the activity of the transcription factor SRF and cell migration , 2015, Science Signaling.

[21]  I. Ng,et al.  Nuclear factor kappa B–mediated CD47 up‐regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice , 2015, Hepatology.

[22]  W. Wagner,et al.  Epigenetic Aging Signatures Are Coherently Modified in Cancer , 2015, PLoS genetics.

[23]  T. Roskams,et al.  Pathogenesis and prognosis of hepatocellular carcinoma at the cellular and molecular levels. , 2015, Clinics in liver disease.

[24]  Yong Ding,et al.  Transcription factor interaction with COMPASS-like complex regulates histone H3K4 trimethylation for specific gene expression in plants , 2015, Proceedings of the National Academy of Sciences.

[25]  X. Dai,et al.  MRTF-A mediates LPS-induced pro-inflammatory transcription by interacting with the COMPASS complex , 2014, Journal of Cell Science.

[26]  D. Michel,et al.  The actin/MKL1 signalling pathway influences cell growth and gene expression through large-scale chromatin reorganization and histone post-translational modifications. , 2014, The Biochemical journal.

[27]  S. Thorgeirsson,et al.  Epigenetic reprogramming modulates malignant properties of human liver cancer , 2014, Hepatology.

[28]  F. Izzo,et al.  Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections. , 2013, Genomics.

[29]  Thomas Gudermann,et al.  Depletion of the transcriptional coactivators megakaryoblastic leukaemia 1 and 2 abolishes hepatocellular carcinoma xenograft growth by inducing oncogene-induced senescence , 2013, EMBO molecular medicine.

[30]  B. Bernstein,et al.  Epigenetic Reprogramming in Cancer , 2013, Science.

[31]  D. Xie,et al.  High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma. , 2012, Human pathology.

[32]  J. Luk,et al.  Interleukin 17A Promotes Hepatocellular Carcinoma Metastasis via NF-kB Induced Matrix Metalloproteinases 2 and 9 Expression , 2011, PloS one.

[33]  S. Mane,et al.  Role for MKL1 in megakaryocytic maturation. , 2009, Blood.

[34]  M. Tai,et al.  Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma , 2003, Cancer.

[35]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..